References
- Aggarwal S, Pittenger MF. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105(4), 1815–22.
- Brosbol-Ravnborg A, Bundgaard B, Hollsberg P. (2013). Synergy between vitamin D(3) and toll-like receptor agonists regulates human dendritic cell response during maturation. Clin Dev Immunol, 2013, 807971.
- Cantorna MT, Snyder L, Lin YD, Yang. L. (2015). Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients, 7(4), 3011–21.
- Carlberg C, Polly P. (1998). Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Exp, 8(1), 19–42.
- Carter L, Fouser LA, Jussif J, et al. (2002). PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol, 32(3), 634–43.
- Choi YS, Jeong JA, Lim DS. (2012). Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest, 41(2), 214–29.
- Dong H, Zhu G, Tamada K, Chen L. (1999). B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med, 5(12), 1365–9.
- Ebrahimi A, Rahim F. (2014). Recent immunomodulatory strategies in transplantation. Immunol Invest, 43(8), 829–37.
- Gregori S. (2011). Dendritic cells in networks of immunological tolerance. Tissue Antigens 77(2), 89–99.
- Griffin MD, Lutz WH, Phan VA, et al. (2000). Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun, 270(3), 701–8.
- Huang H, Dawicki W, Zhang X, et al. 2010. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells. J Immunol, 185 (9), 5003–10.
- Ishida M, Iwai Y, Tanaka Y, et al. (2002). Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 84 (1), 57–62.
- Karachi A, Fazeli M, Karimi MH, et al. (2015). Evaluation of immunomodulatory effects of mesenchymal stem cells soluble factors on miR-155 and miR-23b expression in mice dendritic cells. Immunol Invest, 44 (5), 427–37.
- Kyurkchiev D, Bochev I, Ivanova-Todorova E, et al. (2014). Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells, 6 (5), 552–70.
- Liu YJ. (2005). IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Ann Rev Immunol, 23, 275–306.
- Manolagas SC, Werntz DA, Tsoukas CD, et al. (1986). 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med, 108 (6), 596–600.
- Matta BM, Raimondi G, Rosborough BR, et al. (2012). IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J Immunol, 188 (11), 5227–37.
- Mellor AL, Baban B, Chandler P, et al. (2003). Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol, 171 (4), 1652–5.
- Mellor AL, Munn DH. (2004). IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol, 4 (10), 762–74.
- Murugaiyan G, Mittal A, Weiner HL. (2010). Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci USA, 107 (25), 11495–500.
- Nguyen TM, Pavlovitch J, Papiernik M, et al. (1997). Changes in 1,25-(OH)2D3 synthesis and its receptor expression in spleen cell subpopulations of mice infected with LPBM5 retrovirus. Endocrinology, 138 (12), 5505–10.
- Okazaki T, Honjo T. (2007). PD-1 and PD-1 ligands: From discovery to clinical application. Int Immunol, 19 (7), 813–24.
- Penna G, Amuchastegui S, Giarratana N, et al. (2007). 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol, 178 (1), 145–53.
- Pot C, Jin H, Awasthi A, et al. (2009). Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol, 183 (2), 797–801.
- Rogers NM, Isenberg JS, Thomson AW. (2013). Plasmacytoid dendritic cells: No longer an enigma and now key to transplant tolerance? Am J Trans, 13 (5), 1125–33.
- Sadeghi L, Kamali-Sarvestani E, Azarpira N, et al. (2014). Immunomodulatory effects of mice mesenchymal stem cells on maturation and activation of dendritic cells. Iran J Immunol, 11 (3), 177–88.
- Tuettenberg A, Huter E, Hubo M, et al. (2009). The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J Immunol, 182 (6), 3349–56.
- Uccelli A, Moretta L, Pistoia V. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol, 36 (10), 2566–73.
- Unger WW, Laban S, Kleijwegt FS, et al. (2009). Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1. Eur J Immunol, 39 (11), 3147–59.
- Wakkach A, Fournier N, Brun V, et al. (2003). Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity, 18 (5), 605–17.
- Wolfle SJ, Strebovsky J, Bartz H, et al. (2011). PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol, 41 (2), 413–24.
- Yamazaki T, Akiba H, Iwai H, et al. (2002). Expression of programmed death 1 ligands by murine T cells and APC. J Immunol, 169 (10), 5538–45.
- Zhang B, Liu R, Shi D, et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood, 113 (1), 46–57.
- Zhao ZG, Xu W, Sun L, et al. (2012). Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Invest, 41 (2), 183–98.